Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Labwire Inc. -- Ignore unavailable to you. Want to Upgrade?

To: creede who wrote (858)	5/15/2008 9:23:53 AM
From: xcentral1	Read Replies (2) \| Respond to of 1698

Labwire Signs Alliance Agreement With USIS Market Wire Posted: 2008-05-15 09:06:32 HOUSTON, TX -- (MARKET WIRE) -- 05/15/08 -- Labwire, Inc. (PINKSHEETS: LBWR), a leading provider of employee screening solutions, security, and compliance surveillance services, is pleased to report that on April 30, 2008 Labwire signed an Alliance Agreement with USIS, a large national commercial services group. Under the terms of the Alliance Agreement, Labwire will perform drug/alcohol testing services and pre-employment background screening products and services for certain USIS clients: in turn, USIS will offer their products for sale by Labwire to its clients. The agreement is for an initial term of two (2) years and provides for both firms to pay referral fees based on a percent of business delivered. The initial clients referred by USIS will begin transitioning to Labwire on June 2, 2008 and will continue through year's end and will include several large operating units in commercial transportation industries. "Mr. Morris and the sales team are to be congratulated for securing this substantial relationship agreement," stated Marlin Williford, CFO. "As this agreement is implemented, it should provide good revenue growth for the 3rd and 4th quarters of this year." Dexter Morris, Labwire Chairman and CEO, offers the following business insight: "We are excited about our technology gaining the acceptance of a company such as USIS. We see this as a first step in expanding our client base through alliances as well as direct sales and acquisition opportunities. Labwire will continue to seek this type of alliance agreement with other major companies offering various services. We believe that these alliance arrangements will allow Labwire to grow more rapidly utilizing the strength and effectiveness of its operating platform to grow its revenue at a faster rate than conventional sales would allow." USIS is a worldwide provider of background investigations, pre-employment/drug screenings, insurance information services, due diligence and risk management assessment, and security and related professional services to businesses, federal agencies, and institutions. Headquartered in Falls Church, Va., USIS has more than 7,000 employees supporting business operations in all 50 states, U.S. territories, and overseas. For more information, please visit www.usis.com . Labwire, Inc., headquartered in Houston, TX, provides secure and compliant employee drug screening and background checking services to Fortune 500 corporations via the Labwire(TM) Platform. Labwire(TM) is a proprietary, web-based application that streamlines the complex regulatory and record management activities associated with employee screening, delivering accurate timely results while eliminating service calls and paper trails. This comprehensive solution to managing employee screening services is the most efficient and cost-effective platform in the industry. For more information see 8-k filings.